Z
1.49
0.03 (2.05%)
| Previous Close | 1.46 |
| Open | 1.45 |
| Volume | 33,985 |
| Avg. Volume (3M) | 46,614 |
| Market Cap | 155,423,392 |
| Price / Sales | 3.22 |
| Price / Book | 13.13 |
| 52 Weeks Range | |
| Earnings Date | 25 Jun 2025 - 29 Jun 2025 |
| Operating Margin (TTM) | -6,684.45% |
| Diluted EPS (TTM) | -0.080 |
| Quarterly Revenue Growth (YOY) | 203.70% |
| Total Debt/Equity (MRQ) | 4.69% |
| Current Ratio (MRQ) | 1.83 |
| Operating Cash Flow (TTM) | -6.69 M |
| Levered Free Cash Flow (TTM) | -2.32 M |
| Return on Assets (TTM) | -27.71% |
| Return on Equity (TTM) | -55.12% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bearish | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Bearish | |
| Stock | Zentek Ltd. | Mixed | Mixed |
AIStockmoo Score
0.5
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -0.5 |
| Average | 0.50 |
|
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 6.06% |
| % Held by Institutions | 1.51% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |